Martina Molsbergen

Martina Molsbergen

59 year
Health Technology
Finance
Consumer Services

Profile

Martina Molsbergen was the founder and the Chief Executive Officer of C14 Consulting Group LLC, which was founded in 2009.
She also held the position of Independent Director at Bio-Path Holdings, Inc. from 2019 to 2022.
Ms. Molsbergen was the Vice President of Business Development at Crucell NV and BioWa, Inc. from 2004 to 2007.
She was also the Vice President of Pharmaceutical Development Services at Patheon, Inc. from 1997 to 2001.
Additionally, Ms. Molsbergen held the position of Vice President of Business Development at Quikbyte Software, Inc. and Zetiq Technologies Ltd.
in 2002 and 2003 respectively.
She was the Vice President of Business Development at Sorrento Therapeutics, Inc. in 2009 and from 2009 to 2011.
Currently, Ms. Molsbergen is the Chief Business Officer at Pyxis Oncology, Inc. from 2021 to 2023.
Ms. Molsbergen obtained her undergraduate degree from Drexel University.

Former positions of Martina Molsbergen

CompaniesPositionEnd
PYXIS ONCOLOGY, INC. Corporate Officer/Principal 01/12/2023
BIO-PATH HOLDINGS, INC. Director/Board Member 14/02/2022
SORRENTO THERAPEUTICS, INC. Corporate Officer/Principal 01/07/2011
Corporate Officer/Principal 31/12/2009
Corporate Officer/Principal 31/12/2009
See the detail of Martina Molsbergen's experience

Training of Martina Molsbergen

Drexel University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martina Molsbergen's experience

Connections

30

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
BIO-PATH HOLDINGS, INC.

Health Technology

SORRENTO THERAPEUTICS, INC.

Health Technology

PYXIS ONCOLOGY, INC.

Health Technology

Private companies7

Health Technology

Health Technology

BioWa, Inc.

Finance

Health Technology

Health Technology

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Martina Molsbergen